Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Zack Debra | Chief Medical Officer | 4 | $0 | $0 | 2026-08-03 |
| Tregoning Kathleen | Director | 10 | $0 | $0 | 2026-06-23 |
| Smith Cynthia | Director | 11 | $0 | $0 | 2026-06-23 |
| Jackson Scott Thomas | Director | 9 | $0 | $0 | 2026-06-23 |
| VINK PATRICK V.J.J. | Director | 14 | $0 | $0 | 2026-06-23 |
| Deshpande Milind | Director | 12 | $0 | $0 | 2026-06-23 |
| Pottage John C Jr | Director | 10 | $0 | $0 | 2026-06-23 |
| THOMAS FRANK E | Director | 13 | $0 | $0 | 2026-06-23 |
| Rajavelu Esther | See Remarks | 15 | $0 | $476.0K | 2026-05-04 |
| Keutzer Timothy | Chief Operating Officer | 22 | $0 | $246.4K | 2026-02-06 |
| Mahadevia Ankit | See Remarks | 69 | $0 | $1.04M | 2025-08-28 |
| Shukla Sath | Chief Financial Officer | 20 | $0 | $305.7K | 2025-02-05 |
| HAMED KAMAL | Chief Medical Officer | 6 | $0 | $88.6K | 2024-02-02 |
| JOSEPH TAMARA L | Chief Legal Officer | 9 | $0 | $51.0K | 2024-02-02 |
| Aquilo Capital Management, LLC | 10% Owner | 15 | $8.77M | $4.34M | 2022-09-22 |
| Aquilo Capital, L.P. | 10% Owner | 25 | $13.64M | $11.07M | 2022-04-26 |
| Melnick David A. | Chief Medical Officer | 7 | $0 | $0 | 2022-02-01 |
| Larkin Cristina | Chief Operating Officer | 14 | $21.0K | $298.0K | 2022-02-01 |
| FORMELA JEAN FRANCOIS | Director | 16 | $6.00M | $0 | 2021-08-17 |
| Sendek Joel | Chief Financial Officer | 8 | $70.0K | $35.0K | 2019-01-02 |
| Parr Thomas R JR | Chief Scientific Officer | 2 | $0 | $0 | 2019-01-02 |
| GLAXOSMITHKLINE PLC | 10% Owner | 10 | $7.00M | $0 | 2018-07-17 |
| Breum Casper | Director | 8 | $3.00M | $0 | 2018-06-05 |
| SOUTHWELL DAVID P | Director | 2 | $0 | $0 | 2018-06-05 |
| Goyal Vikas | Director | 9 | $6.00M | $0 | 2017-11-06 |
| Wirtheim Stanley P | Chief Financial Officer | 3 | $0 | $0 | 2015-03-05 |
| Fish Joseph R | EVP & Chief Technology Officer | 3 | $0 | $0 | 2015-03-05 |
| Greene Allen S | Chairman of the Board and CEO | 7 | $32.0K | $0 | 2015-03-05 |
| Fingerhut Jack | President | 4 | $4.8K | $0 | 2015-03-05 |
| STANLEY LEONARD J | Director | 1 | $0 | $0 | 2013-02-05 |
| Martin Lager H | Director | 1 | $0 | $0 | 2013-02-05 |
| GORMAN JOHN J | Director | 2 | $8.7K | $0 | 2013-02-05 |
| Ben-Dov Zohar | 10% Owner | 1 | $27.0K | $0 | 2012-12-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Zack Debra | Chief Medical Officer | A Award deriv | 2026-08-03 | 2026-08-06 | 324,675 | — | $0 | 324,675 | SEC↗ |
| Zack Debra | Chief Medical Officer | A Award | 2026-08-03 | 2026-08-06 | 162,311 | — | $0 | 162,311 | SEC↗ |
| Zack Debra | Chief Medical Officer | A Award deriv | 2026-08-03 | 2026-08-06 | 324,675 | — | $0 | 324,675 | SEC↗ |
| Zack Debra | Chief Medical Officer | A Award | 2026-08-03 | 2026-08-06 | 162,311 | — | $0 | 162,311 | SEC↗ |
| Pottage John C Jr | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Jackson Scott Thomas | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Tregoning Kathleen | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Pottage John C Jr | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| Jackson Scott Thomas | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| THOMAS FRANK E | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| Smith Cynthia | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| Tregoning Kathleen | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| Deshpande Milind | Director | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 101,454 | SEC↗ |
| Rajavelu Esther | See Remarks | S Sale | 2026-05-04 | 2026-05-06 | 25,240 | $2.51 | $63.4K | 986,851 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2026-02-06 | 2026-02-09 | 18,652 | $2.36 | $44.0K | 742,506 | SEC↗ |
| Rajavelu Esther | See Remarks | S Sale | 2026-02-06 | 2026-02-09 | 50,816 | $2.36 | $119.9K | 1,012,091 | SEC↗ |
| Rajavelu Esther | See Remarks | S Sale | 2026-02-06 | 2026-02-09 | 37,101 | $2.36 | $87.6K | 1,062,907 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2026-02-04 | 2026-02-05 | 3,471 | $2.24 | $7.8K | 761,158 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2026-02-03 | 2026-02-05 | 24,224 | $2.14 | $51.8K | 764,629 | SEC↗ |
| Rajavelu Esther | See Remarks | A Award deriv | 2026-02-02 | 2026-02-04 | 498,000 | — | $0 | 498,000 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-05 | 137,000 | — | $0 | 137,000 | SEC↗ |
| Rajavelu Esther | See Remarks | A Award | 2026-02-02 | 2026-02-04 | 249,000 | — | $0 | 1,118,450 | SEC↗ |
| Rajavelu Esther | See Remarks | S Sale | 2026-02-02 | 2026-02-04 | 18,442 | $2.20 | $40.6K | 1,100,008 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | A Award | 2026-02-02 | 2026-02-05 | 68,000 | — | $0 | 807,744 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2026-02-02 | 2026-02-05 | 18,891 | $2.20 | $41.6K | 788,853 | SEC↗ |
| Rajavelu Esther | See Remarks | S Sale | 2025-11-07 | 2025-11-12 | 40,270 | $2.37 | $95.4K | 869,450 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2025-08-28 | 2025-09-03 | 1,695 | $1.97 | $3.3K | 739,744 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2025-08-28 | 2025-09-03 | 6,572 | $1.97 | $12.9K | 703,294 | SEC↗ |
| Tregoning Kathleen | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| THOMAS FRANK E | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| Smith Cynthia | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| Pottage John C Jr | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| Jackson Scott Thomas | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| Deshpande Milind | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 91,454 | SEC↗ |
| Mahadevia Ankit | Director | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 709,866 | SEC↗ |
| Rajavelu Esther | See Remarks | A Award | 2025-05-02 | 2025-05-06 | 185,000 | — | $0 | 909,720 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2025-02-05 | 2025-02-05 | 55,260 | $0.78 | $43.1K | 689,866 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2025-02-05 | 2025-02-05 | 13,959 | $0.78 | $10.9K | 745,126 | SEC↗ |
| Shukla Sath | CEO & President | S Sale | 2025-02-05 | 2025-02-05 | 6,139 | $0.78 | $4.8K | 1,886,077 | SEC↗ |
| Shukla Sath | CEO & President | S Sale | 2025-02-05 | 2025-02-05 | 42,786 | $0.78 | $33.4K | 1,843,291 | SEC↗ |
| Shukla Sath | CEO & President | S Sale | 2025-02-05 | 2025-02-05 | 106,408 | $0.78 | $83.0K | 1,736,883 | SEC↗ |
| Rajavelu Esther | CFO & CBO | S Sale | 2025-02-05 | 2025-02-05 | 20,689 | $0.78 | $16.1K | 724,720 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2025-02-05 | 2025-02-05 | 3,974 | $0.78 | $3.1K | 794,002 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2025-02-05 | 2025-02-05 | 27,643 | $0.78 | $21.6K | 766,359 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2025-02-05 | 2025-02-05 | 24,920 | $0.78 | $19.4K | 741,439 | SEC↗ |
| Shukla Sath | CEO & President | A Award | 2025-02-03 | 2025-02-05 | 751,407 | — | $0 | 1,892,216 | SEC↗ |
| Rajavelu Esther | CFO & CBO | A Award | 2025-02-03 | 2025-02-05 | 266,139 | — | $0 | 645,409 | SEC↗ |
| Rajavelu Esther | CFO & CBO | A Award | 2025-02-03 | 2025-02-05 | 100,000 | — | $0 | 745,409 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | A Award | 2025-02-03 | 2025-02-05 | 266,139 | — | $0 | 797,976 | SEC↗ |
| Rajavelu Esther | CFO & CBO | S Sale | 2024-11-08 | 2024-11-12 | 17,245 | $1.30 | $22.4K | 379,270 | SEC↗ |
| Rajavelu Esther | CFO & CBO | S Sale | 2024-11-07 | 2024-11-12 | 23,351 | $1.31 | $30.6K | 396,515 | SEC↗ |
| Shukla Sath | CEO & President | S Sale | 2024-08-27 | 2024-08-29 | 2,757 | $1.35 | $3.7K | 1,140,809 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2024-08-27 | 2024-08-29 | 2,213 | $1.35 | $3.0K | 531,837 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2024-08-27 | 2024-08-29 | 5,912 | $1.35 | $8.0K | 759,085 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2024-08-05 | 2024-08-06 | 17,641 | $1.31 | $23.1K | 1,143,566 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2024-08-02 | 2024-08-06 | 14,800 | $1.32 | $19.5K | 1,161,207 | SEC↗ |
| Pottage John C Jr | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| THOMAS FRANK E | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| Smith Cynthia | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| Tregoning Kathleen | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| Mahadevia Ankit | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 764,997 | SEC↗ |
| Jackson Scott Thomas | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| Deshpande Milind | Director | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 71,454 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2024-02-05 | 2024-02-05 | 45,093 | $1.45 | $65.4K | 1,176,007 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2024-02-02 | 2024-02-05 | 30,901 | $1.37 | $42.3K | 1,221,100 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | S Sale | 2024-02-02 | 2024-02-05 | 28,075 | $1.37 | $38.5K | 788,117 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | S Sale | 2024-02-02 | 2024-02-05 | 30,906 | $1.37 | $42.3K | 531,615 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2024-02-02 | 2024-02-05 | 63,795 | $1.37 | $87.4K | 744,997 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2024-02-02 | 2024-02-05 | 30,971 | $1.36 | $42.1K | 534,050 | SEC↗ |
| Shukla Sath | CEO and President | A Award | 2024-02-01 | 2024-02-05 | 679,501 | — | $0 | 1,252,001 | SEC↗ |
| Rajavelu Esther | See Remarks | A Award | 2024-02-01 | 2024-02-05 | 119,866 | — | $0 | 419,866 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | A Award | 2024-02-01 | 2024-02-05 | 239,731 | — | $0 | 816,192 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award | 2024-02-01 | 2024-02-05 | 239,731 | — | $0 | 562,521 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | A Award | 2024-02-01 | 2024-02-05 | 239,731 | — | $0 | 565,021 | SEC↗ |
| Tregoning Kathleen | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 35,604 | $1.12 | $39.9K | 35,604 | SEC↗ |
| Rajavelu Esther | See Remarks | A Award | 2023-11-13 | 2023-11-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Mahadevia Ankit | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 808,792 | SEC↗ |
| Jackson Scott Thomas | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| Tregoning Kathleen | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| Deshpande Milind | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 51,454 | SEC↗ |
| THOMAS FRANK E | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| Smith Cynthia | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| Pottage John C Jr | Director | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | S Sale | 2023-09-13 | 2023-09-15 | 39,496 | $1.27 | $50.2K | 576,461 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2023-08-29 | 2023-08-30 | 4,163 | $1.30 | $5.4K | 572,500 | SEC↗ |
| Shukla Sath | CEO and President | S Sale | 2023-08-28 | 2023-08-30 | 1,854 | $1.26 | $2.3K | 576,663 | SEC↗ |
| Mahadevia Ankit | Director | S Sale | 2023-08-28 | 2023-08-30 | 9,040 | $1.26 | $11.4K | 788,792 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | S Sale | 2023-08-28 | 2023-08-30 | 1,854 | $1.26 | $2.3K | 322,790 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | S Sale | 2023-08-28 | 2023-08-30 | 1,854 | $1.26 | $2.3K | 325,290 | SEC↗ |
| Shukla Sath | CEO and President | A Award | 2023-08-01 | 2023-08-03 | 266,000 | — | $0 | 578,517 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | A Award | 2023-06-12 | 2023-06-14 | 140,000 | — | $0 | 615,957 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2023-02-03 | 2023-02-06 | 12,286 | $1.81 | $22.2K | 797,832 | SEC↗ |
| Shukla Sath | Chief Financial Officer | S Sale | 2023-02-02 | 2023-02-03 | 9,504 | $1.83 | $17.4K | 312,517 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | S Sale | 2023-02-02 | 2023-02-03 | 3,394 | $1.86 | $6.3K | 324,644 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | S Sale | 2023-02-02 | 2023-02-03 | 3,394 | $1.86 | $6.3K | 327,144 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award | 2023-02-01 | 2023-02-03 | 531,914 | — | $0 | 810,118 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 475,957 | SEC↗ |
| Shukla Sath | Chief Financial Officer | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 322,021 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 328,038 | SEC↗ |
| Keutzer Timothy | Chief Operating Officer | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 330,538 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 15,471 | $1.29 | $20.0K | 15,471 | SEC↗ |
| Tregoning Kathleen | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 30,943 | $1.29 | $39.9K | 30,943 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | S Sale | 2022-09-22 | 2022-09-26 | 1,335,512 | $2.25 | $3.00M | 3,985,719 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | S Sale | 2022-09-22 | 2022-09-26 | 566,284 | $2.25 | $1.27M | 3,419,435 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Tregoning Kathleen | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THOMAS FRANK E | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Smith Cynthia | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Pottage John C Jr | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Deshpande Milind | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 31,454 | SEC↗ |
| Jackson Scott Thomas | Director | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HAMED KAMAL | Chief Medical Officer | A Award | 2022-09-12 | 2022-09-14 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Shukla Sath | Chief Financial Officer | S Sale | 2022-08-29 | 2022-08-30 | 6,017 | $0.89 | $5.4K | 56,064 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-04-26 | 2022-04-28 | 39,727 | $5.24 | $208.2K | 5,321,231 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-03-30 | 2022-03-31 | 33,115 | $8.79 | $291.1K | 5,264,619 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-03-30 | 2022-03-31 | 16,885 | $8.79 | $148.4K | 5,281,504 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-03-14 | 2022-03-16 | 8,006 | $7.63 | $61.1K | 5,231,504 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-03-14 | 2022-03-16 | 15,702 | $7.63 | $119.8K | 5,223,498 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-02-28 | 2022-03-02 | 29,729 | $9.53 | $283.3K | 5,192,692 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-02-28 | 2022-03-02 | 15,104 | $9.53 | $143.9K | 5,207,796 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-02-18 | 2022-02-23 | 14,828 | $9.24 | $137.0K | 5,162,963 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award deriv | 2022-02-01 | 2022-02-03 | 187,730 | — | $0 | 187,730 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| Shukla Sath | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 62,081 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 64,581 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award | 2022-02-01 | 2022-02-03 | 134,168 | — | $0 | 278,204 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 63,581 | SEC↗ |
| Shukla Sath | Chief Financial Officer | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 62,081 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 62,081 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-01-31 | 2022-02-01 | 125,000 | $11.59 | $1.45M | 5,148,135 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2022-01-24 | 2022-01-26 | 1,599 | $10.89 | $17.4K | 5,023,135 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-01-18 | 2022-01-20 | 48,488 | $12.41 | $601.7K | 5,021,536 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2022-01-10 | 2022-01-12 | 8,867 | $12.93 | $114.7K | 4,973,048 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2022-01-05 | 2022-01-07 | 2,214 | $9.03 | $20.0K | 2,214 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2022-01-05 | 2022-01-07 | 2,214 | $9.03 | $20.0K | 2,214 | SEC↗ |
| Tregoning Kathleen | Director | A Award deriv | 2022-01-05 | 2022-01-07 | 4,428 | $9.03 | $40.0K | 4,428 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-12-31 | 2022-01-03 | 125,000 | $15.75 | $1.97M | 4,964,181 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-12-30 | 2022-01-03 | 50,000 | $15.77 | $788.5K | 4,839,181 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-12-29 | 2022-01-03 | 75,493 | $14.64 | $1.11M | 4,789,181 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2021-12-27 | 2021-12-29 | 8,000 | — | $0 | 486,809 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2021-12-27 | 2021-12-29 | 8,000 | $5.90 | $47.2K | 152,036 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2021-12-27 | 2021-12-29 | 8,000 | $14.58 | $116.6K | 144,036 | SEC↗ |
| Tregoning Kathleen | Director | A Award deriv | 2021-11-11 | 2021-11-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-10-29 | 2021-11-02 | 150,000 | $17.53 | $2.63M | 4,713,688 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-09-30 | 2021-10-04 | 134,543 | $18.65 | $2.51M | 4,563,688 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-09-14 | 2021-09-15 | 2,156 | $18.49 | $39.9K | 4,429,145 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-09-13 | 2021-09-15 | 44,210 | $18.56 | $820.5K | 4,426,989 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-09-09 | 2021-09-10 | 24,749 | $18.50 | $457.9K | 4,382,779 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-08-31 | 2021-09-01 | 48,645 | $18.93 | $920.8K | 4,358,030 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | P Buy | 2021-08-30 | 2021-09-01 | 44,042 | $17.87 | $787.0K | 4,309,385 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-08-27 | 2021-08-27 | 13,957 | $16.88 | $235.6K | 4,265,343 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-08-26 | 2021-08-27 | 22,982 | $16.55 | $380.4K | 4,251,386 | SEC↗ |
| Shukla Sath | Chief Financial Officer | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 24,067 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 26,567 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 24,067 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 25,567 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award | 2021-08-26 | 2021-08-30 | 78,219 | — | $0 | 144,036 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 24,067 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-08-24 | 2021-08-24 | 40,170 | $16.28 | $654.0K | 4,228,404 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-08-23 | 2021-08-24 | 137,835 | $16.33 | $2.25M | 4,188,234 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | P Buy | 2021-08-20 | 2021-08-24 | 221,190 | $14.86 | $3.29M | 4,050,399 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Jackson Scott Thomas | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Pottage John C Jr | Director | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Aquilo Capital Management, LLC | 10% Owner | S Sale | 2021-02-08 | 2021-02-10 | 3,000 | $21.74 | $65.2K | 3,829,209 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2021-02-04 | 2021-02-04 | 34,144 | $18.99 | $648.4K | 3,832,209 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2021-02-03 | 2021-02-04 | 29,354 | $18.98 | $557.1K | 3,866,353 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2021-02-02 | 2021-02-04 | 22,841 | $18.99 | $433.8K | 3,895,707 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 57,432 | — | $0 | 57,432 | SEC↗ |
| Mahadevia Ankit | See Remarks | A Award deriv | 2021-02-01 | 2021-02-03 | 179,319 | — | $0 | 179,319 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 57,432 | — | $0 | 57,432 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 57,432 | — | $0 | 57,432 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2021-02-01 | 2021-02-04 | 13,661 | $19.24 | $262.8K | 3,918,548 | SEC↗ |
| Shukla Sath | Chief Financial Officer | A Award deriv | 2021-01-04 | 2021-01-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 2,629 | $13.31 | $35.0K | 2,629 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 1,314 | $13.31 | $17.5K | 1,314 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 2,629 | $13.31 | $35.0K | 2,629 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 1,314 | $13.31 | $17.5K | 1,314 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-12-17 | 2020-12-18 | 250,000 | $18.81 | $4.70M | 3,932,209 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | M Exercise deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 8,434 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | S Sale | 2020-12-16 | 2020-12-18 | 12,000 | $19.00 | $228.0K | 1,500 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | M Exercise | 2020-12-16 | 2020-12-18 | 12,000 | $5.90 | $70.8K | 13,500 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-12-16 | 2020-12-18 | 14,933 | $18.62 | $278.1K | 4,182,209 | SEC↗ |
| JOSEPH TAMARA L | Chief Legal Officer | A Award deriv | 2020-12-02 | 2020-12-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-11-09 | 2020-11-10 | 125,900 | $13.77 | $1.73M | 4,197,142 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-11-06 | 2020-11-06 | 5,000 | $13.77 | $68.8K | 4,323,042 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-11-05 | 2020-11-06 | 96,600 | $13.98 | $1.35M | 4,328,042 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-11-04 | 2020-11-05 | 7,370 | — | $0 | 494,809 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-11-04 | 2020-11-05 | 7,370 | $5.90 | $43.5K | 73,187 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-11-04 | 2020-11-05 | 7,370 | $14.43 | $106.3K | 65,817 | SEC↗ |
| Aquilo Capital, L.P. | 10% Owner | S Sale | 2020-11-04 | 2020-11-06 | 72,500 | $14.26 | $1.03M | 4,424,642 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-11-03 | 2020-11-05 | 2,137 | — | $0 | 502,179 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-11-03 | 2020-11-05 | 2,137 | $5.90 | $12.6K | 67,954 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-11-03 | 2020-11-05 | 2,137 | $14.27 | $30.5K | 65,817 | SEC↗ |
| Pottage John C Jr | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Jackson Scott Thomas | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-10-23 | 2020-10-27 | 20 | — | $0 | 504,316 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-10-23 | 2020-10-27 | 20 | $5.90 | $118 | 65,837 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-10-23 | 2020-10-27 | 20 | $14.25 | $285 | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-10-14 | 2020-10-15 | 105 | — | $0 | 504,336 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-10-14 | 2020-10-15 | 105 | $5.90 | $620 | 65,922 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-10-14 | 2020-10-15 | 105 | $14.25 | $1.5K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-10-13 | 2020-10-15 | 14,367 | — | $0 | 504,441 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-10-13 | 2020-10-15 | 14,367 | $14.28 | $205.2K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-10-13 | 2020-10-15 | 14,367 | $5.90 | $84.8K | 80,184 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-09-08 | 2020-09-10 | 774 | — | $0 | 518,808 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-09-08 | 2020-09-10 | 774 | $14.25 | $11.0K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-09-08 | 2020-09-10 | 774 | $5.90 | $4.6K | 66,591 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-07-09 | 2020-07-09 | 2,293 | — | $0 | 519,582 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-07-09 | 2020-07-09 | 2,293 | $14.31 | $32.8K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-07-09 | 2020-07-09 | 2,293 | $5.90 | $13.5K | 68,110 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-07-07 | 2020-07-09 | 754 | — | $0 | 521,875 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-07-07 | 2020-07-09 | 754 | $5.90 | $4.4K | 66,571 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-07-07 | 2020-07-09 | 754 | $14.25 | $10.7K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-06-25 | 2020-06-29 | 2,642 | — | $0 | 522,629 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-06-25 | 2020-06-29 | 2,642 | $14.25 | $37.6K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-06-25 | 2020-06-29 | 2,642 | $5.90 | $15.6K | 68,459 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-06-24 | 2020-06-29 | 3,880 | — | $0 | 525,271 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-06-24 | 2020-06-29 | 3,880 | $5.90 | $22.9K | 69,697 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-06-24 | 2020-06-29 | 3,880 | $14.28 | $55.4K | 65,817 | SEC↗ |
| Jackson Scott Thomas | Director | A Award deriv | 2020-06-23 | 2020-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-06-23 | 2020-06-29 | 8,045 | — | $0 | 529,151 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-06-23 | 2020-06-29 | 8,045 | $14.33 | $115.3K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-06-23 | 2020-06-29 | 8,045 | $5.90 | $47.5K | 73,862 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise deriv | 2020-06-22 | 2020-06-29 | 2,613 | — | $0 | 537,196 | SEC↗ |
| Mahadevia Ankit | CEO and President | S Sale | 2020-06-22 | 2020-06-29 | 2,613 | $14.30 | $37.4K | 65,817 | SEC↗ |
| Mahadevia Ankit | CEO and President | M Exercise | 2020-06-22 | 2020-06-29 | 2,613 | $5.90 | $15.4K | 68,430 | SEC↗ |
| Keutzer Timothy | Chief Development Officer | A Award deriv | 2020-02-03 | 2020-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award deriv | 2020-02-03 | 2020-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award deriv | 2020-02-03 | 2020-02-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award deriv | 2020-02-03 | 2020-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 5,408 | $6.47 | $35.0K | 5,408 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 5,408 | $6.47 | $35.0K | 5,408 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 5,408 | $6.47 | $35.0K | 5,408 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 2,704 | $6.47 | $17.5K | 2,704 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Pottage John C Jr | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2019-03-29 | 2019-03-29 | 12,146 | — | $0 | 12,146 | SEC↗ |
| Mahadevia Ankit | CEO and President | A Award deriv | 2019-01-02 | 2019-01-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Sendek Joel | Chief Financial Officer | A Award deriv | 2019-01-02 | 2019-01-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award deriv | 2019-01-02 | 2019-01-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award deriv | 2019-01-02 | 2019-01-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Parr Thomas R JR | Chief Scientific Officer | A Award deriv | 2019-01-02 | 2019-01-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Pottage John C Jr | Director | A Award deriv | 2018-09-21 | 2018-09-21 | 12,146 | — | $0 | 12,146 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | P Buy | 2018-07-17 | 2018-07-17 | 80,000 | $12.50 | $1.00M | 1,934,006 | SEC↗ |
| Mahadevia Ankit | See Remarks | M Exercise deriv | 2018-07-06 | 2018-07-06 | 1,600 | — | $0 | 118,888 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.62 | $1.8K | 66,317 | SEC↗ |
| Mahadevia Ankit | See Remarks | M Exercise | 2018-07-06 | 2018-07-06 | 1,600 | $5.90 | $9.4K | 67,417 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.55 | $1.8K | 66,817 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 500 | $17.50 | $8.8K | 66,917 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 400 | $17.58 | $7.0K | 66,417 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 200 | $17.92 | $3.6K | 65,817 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 200 | $17.90 | $3.6K | 66,017 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.71 | $1.8K | 66,217 | SEC↗ |
| Mahadevia Ankit | See Remarks | M Exercise deriv | 2018-07-05 | 2018-07-06 | 3,076 | — | $0 | 120,488 | SEC↗ |
| Sendek Joel | Chief Financial Officer | M Exercise deriv | 2018-07-05 | 2018-07-06 | 2,000 | — | $0 | 165,833 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | M Exercise deriv | 2018-07-05 | 2018-07-06 | 4,000 | — | $0 | 20,434 | SEC↗ |
| Mahadevia Ankit | See Remarks | S Sale | 2018-07-05 | 2018-07-06 | 3,076 | $17.62 | $54.2K | 65,817 | SEC↗ |
| Mahadevia Ankit | See Remarks | M Exercise | 2018-07-05 | 2018-07-06 | 3,076 | $5.90 | $18.1K | 68,893 | SEC↗ |
| Sendek Joel | Chief Financial Officer | S Sale | 2018-07-05 | 2018-07-06 | 2,000 | $17.50 | $35.0K | 15,181 | SEC↗ |
| Sendek Joel | Chief Financial Officer | M Exercise | 2018-07-05 | 2018-07-06 | 2,000 | $5.90 | $11.8K | 17,181 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | S Sale | 2018-07-05 | 2018-07-06 | 4,000 | $17.50 | $70.0K | 1,500 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | M Exercise | 2018-07-05 | 2018-07-06 | 4,000 | $5.90 | $23.6K | 5,500 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Deshpande Milind | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| Breum Casper | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| SOUTHWELL DAVID P | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| THOMAS FRANK E | Director | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| SOUTHWELL DAVID P | Director | A Award deriv | 2018-03-30 | 2018-03-30 | 12,146 | — | $0 | 12,146 | SEC↗ |
| Melnick David A. | Chief Medical Officer | A Award deriv | 2018-01-04 | 2018-01-05 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Mahadevia Ankit | See Remarks | A Award deriv | 2017-12-13 | 2017-12-15 | 125,079 | — | $0 | 125,079 | SEC↗ |
| Parr Thomas R JR | Chief Scientific Officer | A Award deriv | 2017-12-13 | 2017-12-15 | 36,134 | — | $0 | 36,134 | SEC↗ |
| Sendek Joel | Chief Financial Officer | A Award deriv | 2017-12-13 | 2017-12-15 | 27,795 | — | $0 | 27,795 | SEC↗ |
| Larkin Cristina | Chief Operating Officer | A Award deriv | 2017-12-13 | 2017-12-15 | 62,540 | — | $0 | 62,540 | SEC↗ |